Skip to content

Clinical Study on Jianpi Guchang Formula Combined with Moxibustion in Improving Cancer-related Fatigue

Clinical Study on Jianpi Guchang Formula Combined with Moxibustion in Improving Cancer-related Fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000845
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related Fatigue

Interventions

Comprehensive treatment group:Conventional immunotherapy + oral Jianpi Guchang recipe + moxibustion at Zusanli
Immunotherapy group:Conventional immunotherapy

Sponsors

Shujuan Fu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for malignant tumors, pathological examination confirms the diagnosis, and is TNM stage IV; 2)Comply with ICD-10CRF Western medicine diagnostic standards; 3) Current immunotherapy, or immunotherapy + traditional Chinese medicine treatment; 4)Age 18-80 years old, male or female; 5)KPS score =60 points, expected survival time =3 months; 6) In line with traditional Chinese medicine deficiency syndrome; 7)Patients who prepare their own immunotherapy drugs must sign a consent form for the use of their own drugs.

Exclusion criteria

Exclusion criteria: 1) Those with immune system diseases, severe cardiovascular and cerebrovascular and other serious primary diseases, and mental illness; 2) Those with poor compliance and incomplete data during clinical research; 3)Those whose diagnosis is unclear; 4) Subjects who did not implement the provisions of this experimental protocol; 5) Subjects whose observation items are incomplete and unable to evaluate test effects and side effects; 6)Those who have participated in other clinical trials in the past 3 months; 7)Those who have received other immunotherapy or traditional Chinese medicine treatment that may affect immune function; 8)Those who suffer from other diseases due to non-drug factors during medication and cannot continue treatment; 9)Those who are allergic to mugwort leaves.

Design outcomes

Primary

MeasureTime frame
Piper Fatigue Scale,PFS;

Secondary

MeasureTime frame
Traditional Chinese Medicine Syndrome Score Scale;Karnofsky performance status, KPS;EOTRC Quality of Life Questionnare-Core 30;Intestinal barrier;Inflammatory cytokines;T cell subsets;

Countries

China

Contacts

Public ContactShujuan Fu

Shanghai TCM-Intergrated Hospital2025-

fuxiaofude@163.com13167022326

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026